KIP LITTAU: Open Payments
NPI 1497582340 · PLANKINTON, SD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$388 in 20 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $21 · 2025 $388
Food & beverage: $388
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $217 |
| PFIZER INC. | 2 | $74 |
| Novartis Pharmaceuticals Corporation | 2 | $39 |
| Lilly USA, LLC | 1 | $21 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $16 |
Products named: QULIPTA, NURTEC ODT, VRAYLAR, LEQVIO, MOUNJARO, TRINTELLIX, CAPLYTA.
Industry payments across SD — which companies pay providers there.
